UBS analyst Kevin Caliendo lowered the firm’s price target on Owens & Minor to $7 from $13 and keeps a Buy rating on the shares. Owens & Minor’s Q2 results and outlook were “disappointing,” the analyst tells investors in a research note. While the business is in flux, some positives remain, the firm says.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMI:
- Owens & Minor’s Asset Sale: Potential Risks and Financial Implications
- Owens & Minor price target lowered to $7 from $10 at Baird
- Owens & Minor price target lowered to $4.70 from $7.50 at BofA
- Sell Rating for Owens & Minor Amid Divestiture and Growth Challenges
- Owens & Minor price target lowered to $7 from $11 at Citi